Drug Repurposing Approach, Potential Drugs, and Novel Drug Targets for COVID-19 Treatment. (22nd April 2021)

• Record Type: Journal Article
• Authors: Kifle, Zemene Demelash; Ayele, Akeberegn Gorems; Enyew, Engidaw Fentahun
• Other Names: Broecker Felix Academic Editor.
• Is Part Of: Journal of environmental and public health. Volume 2021(2021)
• Publication Date: 2021-04-22
• Subjects: Environmental health -- Periodicals; Occupational diseases -- Periodicals; Public health -- Periodicals; 613.105
• DOI: 10.1155/2021/6631721
• Languages: English
• ISSNs: 1687-9805

Abstract

Abstract : Novel coronavirus first appeared in Wuhan, China, in December 2019, and it speedily expanded globally. Some medications which are used to treat other diseases seem to be effective in treating COVID-19 even without explicit support. The existing drugs that are summarized in this review primarily focused on therapeutic agents that possessed activity against other RNA viruses such as MERS-CoV and SARS-CoV. Drug repurposing or repositioning is a promising field in drug discovery that identifies new therapeutic opportunities for existing drugs such as corticosteroids, RNA-dependent RNA polymerase inhibitors, interferons, protease inhibitors, ivermectin, melatonin, teicoplanin, and some others. A search for new drug/drug targets is underway. Thus, blocking coronavirus structural protein, targeting viral enzyme, dipeptidyl peptidase 4, and membrane fusion blocker (angiotensin-converting enzyme 2 and CD147 inhibitor) are major sites based on molecular targets for the management of COVID-19 infection. The possible impact of biologics for the management of COVID19 is promising and includes a wide variety of options such as cytokines, nucleic acid-based therapies targeting virus gene expression, bioengineered and vectored antibodies, and various types of vaccines. This review demonstrates that the available data are not sufficient to suggest any treatment for the eradication of COVID-19 to be used at the clinical level. This article aims to review the roles of existing drugs and drug targets for COVID-19 treatment.